SpotLight™

A 30-second, non-invasive optical biosignature screening platform. Real-time biological insights across multiple indications.

SpotLight-C™

Cancer Screening

SpotLight-C™ is under development for non-invasive early-stage cancer detection and real-time chemotherapy response monitoring.

Selected for the 2026 Mayo Clinic & ASU Health Care Accelerator.

SpotLight-19™

Pathogen Detection

SpotLight-19™ was developed during the COVID-19 pandemic and is being expanded to include a range of pathogens, without the need for a biological sample. A 30-second, non-invasive screening test designed for rapid, scalable deployment at point of care.

Invited as participant in the National Security Commission on Emerging Biotechnology Arizona Summit.

Here's how the SpotLight platform is approaching biosensing differently.

ISBRG is targeting world-class compute and AI companies to alter the future of healthcare.